Systematic Financial Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
APM
BTW
Systematic Financial Management's ANIK Position: Q3 2020 in Review
Systematic Financial Management sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 9,255 shares — an estimated $349K sold.
Systematic Financial Management first reported a position in ANIK in Q3 2013 and held it in 17 quarters. The position peaked at $26.4M in Q1 2014. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.
- Systematic Financial Management reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
- Systematic Financial Management sold 9,255 Anika Therapeutics shares in Q3 2020, an estimated $349K.
- Systematic Financial Management first reported a position in Anika Therapeutics in Q3 2013 and held it in 17 quarters.
- Systematic Financial Management's Anika Therapeutics position peaked at $26.4M in Q1 2014.
- 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.
Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.